Pine Bridge Investments, L.P. Spectrum Pharmaceuticals Inc Transaction History

Pine Bridge Investments, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$1.83 - $3.45 $140,373 - $264,639	-76,707 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$3.5 - $10.35 $144,091 - $426,099	-41,169 Reduced 34.93%	76,707 $279,000
Q3 2019 Nov 13, 2019	BUY	$7.03 - $9.7 $36,506 - $50,372	5,193 Added 4.61%	117,876 $978,000
Q2 2019 Aug 13, 2019	BUY	$7.36 - $11.26 $630,074 - $963,946	85,608 Added 316.19%	112,683 $971,000
Q1 2019 May 14, 2019	SELL	$9.08 - $11.84 $29,873 - $38,953	-3,290 Reduced 10.83%	27,075 $289,000
Q4 2018 Feb 13, 2019	SELL	$6.39 - $16.99 $205,630 - $546,738	-32,180 Reduced 51.45%	30,365 $266,000
Q3 2018 Nov 13, 2018	SELL	$16.52 - $24.82 $39,119 - $58,773	-2,368 Reduced 3.65%	62,545 $1.05 Million
Q2 2018 Aug 09, 2018	SELL	$14.31 - $21.75 $41,742 - $63,444	-2,917 Reduced 4.3%	64,913 $1.36 Million
Q1 2018 May 14, 2018	SELL	$16.09 - $23.07 $1.22 Million - $1.75 Million	-75,882 Reduced 52.8%	67,830 $1.09 Million
Q4 2017 Feb 09, 2018	BUY	$13.36 - $20.73 $265,676 - $412,236	19,886 Added 16.06%	143,712 $2.72 Million
Q3 2017 Nov 13, 2017	SELL	$8.75 - $14.07 $32,217 - $51,805	-3,682 Reduced 2.89%	123,826 $1.74 Million
Q2 2017 Aug 11, 2017	BUY	N/A	127,508	127,508 $950,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.